HRT Financial’s Gain Therapeutics GANX Stock Holding History
Bought
Maintained
Sold
Other funds holding GANX
PCM
HRT Financial's GANX Position: Q3 2026 in Review
HRT Financial opened a new position in Gain Therapeutics (GANX) in Q3 2026: 14,903 shares worth $25K. The stake represents ﹤0.01% of the portfolio and ranks #4506 among its holdings. This is a return to the name: HRT Financial previously reported a position in GANX as recently as Q4 2025.
HRT Financial first reported a position in GANX in Q3 2025 and has held it in 3 quarters since. The position peaked at $179K in Q4 2025. 50 funds tracked by Wall St. Rank hold GANX as of Q3 2026.
- HRT Financial held 14,903 shares of Gain Therapeutics worth $25K as of Q3 2026.
- Gain Therapeutics was a new HRT Financial position in Q3 2026.
- Gain Therapeutics made up ﹤0.01% of HRT Financial's portfolio in Q3 2026, its #4506 holding.
- HRT Financial first reported a position in Gain Therapeutics in Q3 2025 and has held it in 3 quarters since.
- HRT Financial's Gain Therapeutics position peaked at $179K in Q4 2025.
- 50 funds tracked by Wall St. Rank held Gain Therapeutics as of Q3 2026.
Based on HRT Financial's 13F filing for Q3 2026, filed 13 Nov 2026.